Akari Therapeutics, Plc (AKTX)

SEC filing

Akari Therapeutics, Plc

AKTX · CIK 1541157

4 · Oct 1, 2026 · Director, CEO Gaslightwala Abizer was granted 6,430 American Depositary Shares representing Ordinary Shares at $9.72/unit ($62,500)

Director, CEO Gaslightwala Abizer was granted 6,430 American Depositary Shares representing Ordinary Shares at $9.72/unit ($62,500)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).